Shattuck Labs (STTK) Current Assets (2019 - 2026)
Shattuck Labs (STTK) reported Current Assets of $93.8 million for Q1 2026, up 41.19% year-over-year from $66.4 million in Q1 2025, and up 13.67% quarter-over-quarter from $82.5 million in Q4 2025.
Shattuck Labs (STTK) Current Assets (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Current Assets data on file, last reported at $93.8 million in Q1 2026.
- Current Assets for Q1 2026 came in at $93.8 million, up 41.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $93.8 million (up 41.19% YoY), and the FY2025 annual result was $82.5 million, up 4.12% from the prior year.
- Current Assets climbed to $93.8 million in Q1 2026 per STTK's latest filing, from $82.5 million in the prior quarter.
- Over five years, Current Assets peaked at $255.0 million in Q1 2022 and troughed at $54.7 million in Q2 2025.
- A 5-year average of $131.3 million and a median of $114.4 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2025 and 2026: Current Assets sank 52.22% in 2025, then jumped 41.19% in 2026.
- A 5-year view of Current Assets shows it stood at $184.6 million in 2022, then decreased by 22.41% to $143.2 million in 2023, then tumbled by 44.69% to $79.2 million in 2024, then advanced by 4.12% to $82.5 million in 2025, then grew by 13.67% to $93.8 million in 2026.
- Business Quant data shows STTK's Current Assets at $93.8 million in Q1 2026, $82.5 million in Q4 2025, and $90.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 93.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.75 Mn |
| Dec 31, 2025 | 82.48 Mn |
| Sep 30, 2025 | 90.72 Mn |
| Jun 30, 2025 | 54.68 Mn |
| Mar 31, 2025 | 66.40 Mn |
| Dec 31, 2024 | 79.22 Mn |
| Sep 30, 2024 | 98.74 Mn |
| Jun 30, 2024 | 114.43 Mn |
| Mar 31, 2024 | 131.08 Mn |
| Dec 31, 2023 | 143.22 Mn |
| Sep 30, 2023 | 112.99 Mn |
| Jun 30, 2023 | 136.45 Mn |
| Mar 31, 2023 | 157.84 Mn |
| Dec 31, 2022 | 184.58 Mn |
| Sep 30, 2022 | 201.52 Mn |
| Jun 30, 2022 | 229.42 Mn |
| Mar 31, 2022 | 254.99 Mn |
| Dec 31, 2021 | 288.27 Mn |
| Sep 30, 2021 | 301.64 Mn |
| Jun 30, 2021 | 315.88 Mn |